mouse anti-calbindin antiserum (Swant)
Structured Review

Mouse Anti Calbindin Antiserum, supplied by Swant, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-calbindin+antiserum/pmc02670451-84-14-19?v=Swant
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Structural Correlates of Efficient GABAergic Transmission in the Basal Ganglia-Thalamus Pathway"
Article Title: Structural Correlates of Efficient GABAergic Transmission in the Basal Ganglia-Thalamus Pathway
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
doi: 10.1523/JNEUROSCI.5266-07.2008
Figure Legend Snippet: Topography of nigrothalamic terminals and their relationship to calbindin immunostaining in the rat. A, Schematic labeling of five injection sites in the SNR shown at five coronal levels of the atlas of Paxinos and Watson (1998). B-G, Distribution of the dense core of nigrothalamic terminal fields in the thalamus, color coded according to the labeling in A. Scattered fibers are omitted for clarity. The outlines of the terminal fields are shown overlaid on calbindin-immunostained coronal sections of the thalamus sampled 300 μm apart. Note the dual terminal fields in the ventromedial and intralaminar nuclei and the long anteroposterior extent of the terminal fields. Caudal SNR injections result in more dense intralaminar fiber plexuses, whereas rostral injections label only few fibers in these nuclei. H, I, Light microscopic images of the VM double stained for BDA (black) and calbindin (brown) after injection of the tracer into SNR. The boxed area in H is shown enlarged in I. Nigrothalamic terminals (arrows in I) are restricted to the zone containing calbindin-immunoreactive cells (asterisks). J, Nigrothalamic terminals establish multiple contacts (arrows) on the soma of a calbindin-positive relay cell. I and J are multifocal images. Scalebars:B-G, 1 mm; H, 200 μm; I, 50 μm; J, 10 μm. AV, Anteroventral thalamic nucleus (n.); CL, centrolateral thalamic n.; F, nucleus of the fields of Forel; fr, fasciculus retroflexus; Hb, habenular n.; LD, laterodorsal thalamic n.; LH, lateral hypothalamic area; LP, lateral posterior thalamic n.; MD, mediodorsal thalamic n.; ml, medial lemniscus; mt, mammillothalamic tract; PaR, pararubral nucleus; PC, paracentral thalamic n.; PR, prerubral field; Po, posterior thalamic n. group; RMC, red nucleus, magnocellular part; RPC, red nucleus, parvicellular part; sm, stria medullaris of thalamus; SNC, substantia nigra, compact part; Sub, submedius thalamic n.; VA, ventral anterior thalamic n.; VL, ventrolateral thalamic n.; VTA, ventral tegmental area; ZID, zona incerta dorsal part; ZIV, zona incerta ventral part.
Techniques Used: Immunostaining, Labeling, Injection, Staining
